Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4. Patients with contrast-induced nephropathy
Patient No. Baseline SCr (mg/dL) First Postcontrast SCr (mg/dL) Second Postcontrast SCr (mg/dL)
Control Group 
    12^† 1.00 1.04 1.38
    20^† 0.69 0.80 0.87
    22^† 0.40 0.44 0.60
    29^*,^‡ 4.04 4.59 4.77
    43^† 1.30 1.53 2.19
    46^† 0.48 0.76 0.79
    60^† 0.88 1.10 1.22
    61^† 0.84 1.28 1.92
    63^† 1.06 1.00 1.38
    73^† 1.32 1.30 1.73
    75^† 0.79 0.94 1.11
    76^†,^* 2.08 2.16 2.73
Patient Group 
    30^† 0.51 0.58 0.66
    42^† 0.94 1.29 1.38
    47^† 0.71 0.64 0.89
    48^† 0.63 0.58 0.88
    58^† 1.11 1.13 1.39
    70^† 0.58 0.67 0.79
    83^† 0.62 0.75 0.86
Note:—SCr indicates serum creatinine
* , increase of greater than or equal to 0.5 mg/dL
† , increase of greater than or equal to 25%
‡ , elevated baseline SCr.

Patient No.	Baseline SCr (mg/dL)	First Postcontrast SCr (mg/dL)	Second Postcontrast SCr (mg/dL)
Control Group
12^†	1.00	1.04	1.38
20^†	0.69	0.80	0.87
22^†	0.40	0.44	0.60
29^*,^‡	4.04	4.59	4.77
43^†	1.30	1.53	2.19
46^†	0.48	0.76	0.79
60^†	0.88	1.10	1.22
61^†	0.84	1.28	1.92
63^†	1.06	1.00	1.38
73^†	1.32	1.30	1.73
75^†	0.79	0.94	1.11
76^†,^*	2.08	2.16	2.73
Patient Group
30^†	0.51	0.58	0.66
42^†	0.94	1.29	1.38
47^†	0.71	0.64	0.89
48^†	0.63	0.58	0.88
58^†	1.11	1.13	1.39
70^†	0.58	0.67	0.79
83^†	0.62	0.75	0.86